Steven Paul Balk, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Steven Balk's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Steven Balk has written about over time.
Receptors, Antigen, T-Cell, alpha-betaAntigens, CD1T-Lymphocyte SubsetsAntigens, CD1dNeoplasms, Hormone-DependentTranscription, GeneticProstatic NeoplasmsAndrogen AntagonistsAndrogen Receptor AntagonistsReceptors, AndrogenAndrogensProtein Phosphatase 1Natural Killer T-CellsCell Line, TumorGene Expression Regulation, NeoplasticDrug Resistance, NeoplasmAndrostenesReceptor Tyrosine Kinase-like Orphan Receptors
To see the data from this visualization as text,
click here.
| Name | Number of Publications | First Publication Year | Most Recent Publication Year | Average Publication Date |
|---|
| Receptors, Antigen, T-Cell, alpha-beta | 22 | 1991 | 2014 | December 1998 |
| Antigens, CD1 | 44 | 1989 | 2010 | June 1999 |
| T-Lymphocyte Subsets | 27 | 1993 | 2017 | April 2002 |
| Antigens, CD1d | 23 | 1989 | 2017 | September 2004 |
| Neoplasms, Hormone-Dependent | 12 | 1999 | 2013 | April 2007 |
| Transcription, Genetic | 26 | 1988 | 2024 | March 2009 |
| Prostatic Neoplasms | 107 | 1995 | 2024 | April 2011 |
| Androgen Antagonists | 26 | 1996 | 2022 | June 2011 |
| Androgen Receptor Antagonists | 19 | 2001 | 2022 | August 2011 |
| Receptors, Androgen | 96 | 1995 | 2024 | February 2012 |
| Androgens | 34 | 1997 | 2023 | May 2012 |
| Protein Phosphatase 1 | 4 | 2008 | 2017 | November 2012 |
| Natural Killer T-Cells | 8 | 2009 | 2022 | January 2014 |
| Cell Line, Tumor | 67 | 2003 | 2024 | June 2014 |
| Gene Expression Regulation, Neoplastic | 43 | 1999 | 2024 | November 2014 |
| Drug Resistance, Neoplasm | 18 | 2006 | 2021 | February 2016 |
| Androstenes | 14 | 2011 | 2021 | May 2016 |
| Receptor Tyrosine Kinase-like Orphan Receptors | 2 | 2022 | 2023 | October 2022 |